Health Catalyst, Inc. Stockholders Equity

Quick Answer

Health Catalyst, Inc. reported Stockholders Equity of $245.78 million for fiscal year 2025.

Health Catalyst, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $245.78M -32.7%
2024 $365.21M -0.5%
2023 $366.92M -13.7%
2022 $425.01M -18.6%
2021 $522.10M +89.1%
2020 $276.10M +37.6%
2019 $200.64M +153.5%
2018 -$374.77M -44.4%
2017 -$259.48M -25.7%
2016 -$206.41M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $331.92M -6.5% -4.5%
June 30, 2025 $347.55M -2.6% -7.8%
March 31, 2025 $376.81M +5.5% +3.2%
December 31, 2024 $365.21M -0.5% +2.9%
September 30, 2024 $355.04M -7.2% -0.6%
June 30, 2024 $357.00M -8.4% -0.1%
March 31, 2024 $357.21M -11.8% -2.6%
December 31, 2023 $366.92M -13.7% -4.0%
  • Health Catalyst, Inc. showed a decrease of -32.7% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2016–2025 period, Health Catalyst, Inc.’s stockholders equity has grown by 219.1% (from -$206.41 million to $245.78 million).
  • The most recent figure is from Health Catalyst, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment